Nondisclosure of Medical Related Information | PPA - Dove Medical Press
Overview
Javascript is curently disabled in your browser. Several features of this site wil not function whilst javascript is disabled.open aces to scientific and medical researchPapers PublishedOpen aces per-reviewed scientific and medical journals.Learn moreDove Medical Pres is a member of the OAI.Learn moreBulk reprints for the pharmaceutical industry.Learn moreWe ofer real benefits to our authors, including fast-track procesing of papers.Learn moreRegister your specific details and specific drugs of interest and we wil match the information you provide to articles from our extensive database and email PDF copies to you promptly.Learn moreBack to Journals » Patient Preference and Adherence » Volume 16 Authors Alrashed A, Wafa AN, Hamouda RH, Alharthi SA, AlMotairi HM, Alsadhan KF, AlSaif HI , Almigbal TH Received 6 September 2022 Acepted for publication 2 October 2022 Published 28 October 2022 Volume 2022:16 Pages 2937—2945 DOI htps:/doi.org/10.2147/PA.S387915 Checked for plagiarism Yes Review by Single anonymous per review Per reviewer coments 3 Editor who aproved publication: Profesor Qizhi (Cathy) Yao Abdulah Alrashed,1,2 Amal N Wafa,3 Reham Hamouda,4 Sawsan Alharthi,5 Hour M AlMotairi,3 Khalid F Alsadhan,1,2 Haytham I AlSaif,1,2 Turky H Almigbal1,2 1Department of Family and Comunity Medicine, Colege of Medicine, King Saud University, Riyadh, Saudi Arabia; 2King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia; 3Department of Family Medicine, Vision Colege of Medicine, Vision Coleges, Riyadh, Saudi Arabia; 4Department of Family Medicine, Colege of Medicine, AlMarefah University, Riyadh, Saudi Arabia; 5Department of Family Medicine, Colege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi ArabiaCorespondence: Abdulah Alrashed, Department of Family and Comunity Medicine, Colege of Medicine, King Saud University, Riyadh, Saudi Arabia, Tel +96 5 6
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article